Treatment - Page 13 of 471 Posts on Medivizor
Navigation Menu

Treatment Posts on Medivizor

Evaluating combined treatment of venetoclax and gilteritinib for relapsed or refractory acute myeloid leukemia with the FLT3 mutation.

Evaluating combined treatment of venetoclax and gilteritinib for relapsed or refractory acute myeloid leukemia with the FLT3 mutation.

Posted by on Jan 8, 2023 in Leukemia | 0 comments

In a nutshell This study evaluated the tolerability and effectiveness of combined therapy using venetoclax (Venclexta) and gilteritinib (Xospata) in patients with relapsed or refractory (r/r) acute myeloid leukemia (AML) with the FLT3 (FMS-related tyrosine kinase 3) mutation. The data showed that a combination of venetoclax and gilteritinib potentially...

Read More

How effective and safe is dapagliflozin as an add-on therapy to insulin in patients with type 1 diabetes?

How effective and safe is dapagliflozin as an add-on therapy to insulin in patients with type 1 diabetes?

Posted by on Jan 8, 2023 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the most effective and safe dose of dapagliflozin (Farxiga) as an additional treatment to insulin in patients with type 1 diabetes (T1D). The authors concluded that 10 mg of dapagliflozin as an add-on to insulin treatment resulted in improved blood glucose (sugar) control, reduced insulin dosage, and body...

Read More

Evaluating the safety and effectiveness of FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of metastatic colorectal cancer

Evaluating the safety and effectiveness of FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of metastatic colorectal cancer

Posted by on Jan 8, 2023 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) plus bevacizumab (Avastin) with or without atezolizumab (Tecentriq) on the outcomes of patients with metastatic (m) colorectal cancer (CRC). The study showed that adding atezolizumab to FOLFOXIRI plus...

Read More

Evaluating the effectiveness and safety of ivabradine in combination with beta-blockers in patients with stable angina.

Evaluating the effectiveness and safety of ivabradine in combination with beta-blockers in patients with stable angina.

Posted by on Jan 8, 2023 in Coronary artery disease | 0 comments

In a nutshell This study evaluated the effectiveness and safety of ivabradine (Procoralan) in combination with beta-blockers in patients with stable angina. The data showed that the combination of ivabradine plus beta-blocker therapy effectively reduced heart rate, angina symptoms, and the use of short-acting nitrates from the first month of treatment...

Read More

Evaluating the optimal treatment regimens given before and after surgery in improving survival outcomes in patients with HER2-positive breast cancer.

Evaluating the optimal treatment regimens given before and after surgery in improving survival outcomes in patients with HER2-positive breast cancer.

Posted by on Jan 8, 2023 in Breast cancer | 0 comments

In a nutshell This study evaluated the optimal treatment regimens given before and after surgery in terms of improving the survival outcomes in patients with human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC). The data showed that chemotherapy plus trastuzumab (Herceptin) and pertuzumab (Perjeta) was the best treatment...

Read More

Evaluating the effects of metformin and exenatide on pregnancy rate and pregnancy outcomes in overweight or obese infertile women with PCOS.

Evaluating the effects of metformin and exenatide on pregnancy rate and pregnancy outcomes in overweight or obese infertile women with PCOS.

Posted by on Jan 8, 2023 in Infertility | 0 comments

In a nutshell This study compared the effects of metformin (Glucophage) and exenatide (Byetta) on pregnancy rate and pregnancy outcomes in overweight or obese infertile women with polycystic ovary syndrome (PCOS). The data showed that 12 weeks of exenatide treatment before pregnancy improved spontaneous pregnancy in these women. Some background...

Read More

Evaluating the effectiveness and safety of transanal versus laparoscopic total mesorectal resection for the treatment of patients with rectal cancer.

Evaluating the effectiveness and safety of transanal versus laparoscopic total mesorectal resection for the treatment of patients with rectal cancer.

Posted by on Jan 8, 2023 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the effectiveness and safety of transanal (ta) versus laparoscopic (lap) total mesorectal resection (TME) for the treatment of patients with stage I-III rectal cancer (RC). The data showed that experienced surgeons can safely perform taTME in these patients. Some background Rectal cancer (RC) is one of the most...

Read More

Evaluating the effectiveness of abemaciclib alone or in combination with tamoxifen in patients with HR+, HER2– metastatic breast cancer resistant to hormone therapy.

Evaluating the effectiveness of abemaciclib alone or in combination with tamoxifen in patients with HR+, HER2– metastatic breast cancer resistant to hormone therapy.

Posted by on Jan 8, 2023 in Breast cancer | 0 comments

In a nutshell This study evaluated the effectiveness of abemaciclib (Verzenio) alone or in combination with tamoxifen (Nolvadex) in patients with hormone receptor-positive (HR+)/HER2-negative (HER2-) metastatic breast cancer (BC) resistant to hormone therapy. The data showed that abemaciclib in combination with tamoxifen was more effective in improving...

Read More

Can remission be increased in patients with rheumatoid arthritis by using more biologics and less corticosteroids under real-life conditions?

Can remission be increased in patients with rheumatoid arthritis by using more biologics and less corticosteroids under real-life conditions?

Posted by on Jan 3, 2023 in Rheumatoid Arthritis | 0 comments

In a nutshell This study evaluated the 7-year follow-up remission rate and maintenance in patients with rheumatoid arthritis (RA) under real-life conditions and identified factors related to long-term remission. The authors concluded that at 7 years nearly twice as many patients were in remission than at 1 year of follow-up and those patients had mainly...

Read More

Evaluating the effectiveness of transanal endoscopic microsurgery for the treatment of early rectal cancer in patients over 60 years old with high surgical risk.

Evaluating the effectiveness of transanal endoscopic microsurgery for the treatment of early rectal cancer in patients over 60 years old with high surgical risk.

Posted by on Jan 3, 2023 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the effectiveness of transanal endoscopic microsurgery (TEM) for the treatment of early rectal cancer (RC) in patients over 60 years old with high surgical risk. The data showed that TEM is a reliable and effective treatment option in high-risk patients over 60 years old. Some background Rectal cancer (RC) is one of...

Read More

Evaluating the effect of patient-reported physical and mental health status before PCI/CABG on their long-term outcomes

Evaluating the effect of patient-reported physical and mental health status before PCI/CABG on their long-term outcomes

Posted by on Jan 3, 2023 in Coronary artery disease | 0 comments

In a nutshell This study evaluated the effect of patient-reported physical and mental health status before revascularization procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) on their long-term outcomes in patients with coronary artery disease (CAD). The data showed that...

Read More

Comparing the effects of a ketogenic diet versus a Mediterranean diet on glucose control in patients with prediabetes and type 2 diabetes.

Comparing the effects of a ketogenic diet versus a Mediterranean diet on glucose control in patients with prediabetes and type 2 diabetes.

Posted by on Jan 3, 2023 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effects of a ketogenic diet (KD) versus a Mediterranean diet (MD) on glucose control in patients with prediabetes and type 2 diabetes (T2D). The data showed that the less restrictive MD was as effective in controlling glucose as a KD and likely more likely to be maintained in the long term. There...

Read More